CBLL

Ceribell Stock Analysis

AI Rating

Low
  • Quality2/10
  • Growth↓ 2/10
  • Value↓ 0/10
Ceribell sales and earnings growth
CBLL Growth
Fair
  • Revenue Y/Y↑ 26.64%
  • EPS Y/Y↑ 25.57%
  • FCF Y/Y↓ -29.14%
Ceribell gross and profit margin trends
CBLL Profitability
Neutral
  • Gross margin ↑ 87.70%
  • EPS margin↓ -63.50%
  • ROIC 5Y↓ 0.00%
Ceribell net debt vs free cash flow
CBLL Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -31.6

Ceribell stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Medical Devices stocks